Ariel Lopez-Chavez, MD

Dr. Ariel Lopez-Chavez is the director of the AHN Cancer Institute’s Precision Medicine and Developmental Therapeutics Center of Excellence. A world-renowned expert in medical oncology and precision cancer medicine, he has pioneered the development of numerous cancer treatments, many of which are now FDA-approved and are helping cancer patients live significantly longer lives.

AHNCI’s Precision Medicine and Developmental Therapeutics Clinic focuses on serving patients who may need an in-depth review of their cancer treatment plan and a second opinion or are seeking novel treatment options for rare, complex, or advanced-stage cancers.

From the latest technologies in targeted therapies, immunotherapies, and cellular therapies, to the use of novel clinical algorithms and empowerment programs to guide and support patient care, the Precision Medicine and Developmental Therapeutics Center of Excellence provides cancer patients with access to treatments and interventions most likely to increase their chances of recovery.

Dr. Lopez-Chavez is a medical oncologist certified by the American Board of Internal Medicine, specializing in precision cancer medicine for patients whose cancer has progressed despite initial treatment and are seeking novel treatment options.

Before joining AHNCI, he was a Medical Director and Global Head of Oncology Development Innovation at Genentech-Roche, one of the largest life sciences companies in the world and the worldwide leader in the development of innovative cancer medicines. He has also worked and/or held leadership positions at several top cancer centers in the United States, including the National Cancer Center Institute in Bethesda, Maryland; the Knight Cancer Institute at Organ Health and Sciences University; the Sylvester Comprehensive Cancer Center at the University of Miami; and the Walter Reed National Military Medical Center, where he was named one of the top five oncologists for exceptional customer service.